Blood glucose control contributes to protein stability of Ski‑related novel protein N in a rat model of diabetes

Liang,Luqun; Li,Shuang; Liu,Huiming; Mao,Yanwen; Liu,Lingling; Zhang,Xiaohuan; Peng,Wei; Xiao,Ying; Zhang,Fan; Shi,Mingjun; Wang,Yuanyuan; Guo,Bing

doi:10.3892/etm.2021.10776

Blood glucose control contributes to protein stability of Ski‑related novel protein N in a rat model of diabetes

Authors:
- Luqun Liang
- Shuang Li
- Huiming Liu
- Yanwen Mao
- Lingling Liu
- Xiaohuan Zhang
- Wei Peng
- Ying Xiao
- Fan Zhang
- Mingjun Shi
- Yuanyuan Wang
- Bing Guo
View Affiliations

Affiliations: State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China, Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China
Published online on: September 22, 2021 https://doi.org/10.3892/etm.2021.10776
Article Number: 1341

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ski‑related novel protein N (SnoN) negatively regulates the transforming growth factor‑β1 (TGF‑β1)/Smads signaling pathway and is present at a low level during diabetic nephropathy (DN), but its underlying regulatory mechanism is currently unknown. The present study aimed to assess the effects of insulin‑controlled blood glucose on renal SnoN expression and fibrosis in rats with diabetes mellitus (DM). Streptozotocin‑induced DM rats were treated with insulin glargine (INS group) following successful model establishment. Blood samples were collected and centrifuged for biochemical indexes and the kidneys were collected for morphological analysis. In vitro, rat renal proximal tubular epithelial cells were treated with high‑glucose medium for 24 h and transferred to normal glucose medium for 24 h. The expression levels of TGF‑β1, SnoN, Smad ubiquitin regulatory factor 2 (Smurf2), Arkadia, Smads, E‑cadherin, α‑smooth muscle actin and collagen III were assessed by western blotting and immunohistochemistry. The ubiquitylation of SnoN was detected by immunoprecipitation, and the expression levels of SnoN mRNA were evaluated by reverse transcription‑quantitative PCR. The biochemical parameters and morphology indicated that renal fibrosis was notable in the DM group and mitigated in the INS group. Compared with the control group, TGF‑β1, phosphor (p)‑Smad2, p‑Smad3, Smurf2 and Arkadia levels were enhanced in the DM group, and the levels of SnoN protein were decreased, whereas the levels of SnoN mRNA and ubiquitylation were increased in renal tissues. Notably, treatment with insulin reversed this trend. Furthermore, changing the glucose levels in the medium from high to normal glucose suppressed the epithelial‑mesenchymal transition of NRK‑52E cells by restoring the SnoN protein levels, and this phenomenon was impaired by the knockout of SnoN. SnoN protein levels were likely reduced through a mechanism enhanced by the ubiquitin proteasome system, which reversed the transcriptional activation of SnoN during DN progression. In addition, controlling blood glucose may delay DN fibrosis by rescuing the protein stability of SnoN.

View Figures

View References

1	Flyvbjerg A: The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 13:311–318. 2017.PubMed/NCBI View Article : Google Scholar
2	Gu W, Liu Y, Chen Y, Deng W, Ran X, Chen L, Zhu D, Yang J, Shin J, Lee SW, et al: Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose. Diabetes Metab. 43:359–363. 2017.PubMed/NCBI View Article : Google Scholar
3	Valencia WM and Florez H: How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. 356(i6505)2017.PubMed/NCBI View Article : Google Scholar
4	Xiong Y and Zhou L: The Signaling of Cellular Senescence in Diabetic Nephropathy. Oxid Med Cell Longev. 2019(7495629)2019.PubMed/NCBI View Article : Google Scholar
5	Li J, Wu B, Hu H, Fang X, Liu Z and Wu S: GdCl3 attenuates the glomerular sclerosis of streptozotocin (STZ) induced diabetic rats via inhibiting TGF-β/Smads signal pathway. J Pharmacol Sci. 142:41–49. 2020.PubMed/NCBI View Article : Google Scholar
6	Sutariya B, Jhonsa D and Saraf MN: TGF-β: The connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol. 38:39–49. 2016.PubMed/NCBI View Article : Google Scholar
7	Zeglinski MR, Hnatowich M, Jassal DS and Dixon IM: SnoN as a novel negative regulator of TGF-β/Smad signaling: A target for tailoring organ fibrosis. Am J Physiol Heart Circ Physiol. 308:H75–H82. 2015.PubMed/NCBI View Article : Google Scholar
8	Liu R, Wang Y, Xiao Y, Shi M, Zhang G and Guo B: SnoN as a key regulator of the high glucose-induced epithelial-mesenchymal transition in cells of the proximal tubule. Kidney Blood Press Res. 35:517–528. 2012.PubMed/NCBI View Article : Google Scholar
9	Liu L, Wang Y, Yan R, Li S, Shi M, Xiao Y and Guo B: Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway. PLoS One. 11(e0151986)2016.PubMed/NCBI View Article : Google Scholar
10	Luo DD, Phillips A and Fraser D: Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am J Pathol. 176:1139–1147. 2010.PubMed/NCBI View Article : Google Scholar
11	Jahchan NS and Luo K: SnoN in mammalian development, function and diseases. Curr Opin Pharmacol. 10:670–675. 2010.PubMed/NCBI View Article : Google Scholar
12	Liu S, Yu N, Zhang XL, Chen XQ and Tang LQ: Regulatory effect of berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy. Zhongguo Zhongyao Zazhi. 37:3604–3610. 2012.PubMed/NCBI(In Chinese).
13	Sakairi T, Hiromura K, Takahashi S, Hamatani H, Takeuchi S, Tomioka M, Maeshima A, Kuroiwa T and Nojima Y: Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo. Nephrology (Carlton). 16:76–86. 2011.PubMed/NCBI View Article : Google Scholar
14	Wang Y, Zhang X, Mao Y, Liang L, Liu L, Peng W, Liu H, Xiao Y, Zhang Y, Zhang F, et al: Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN. Exp Mol Pathol. 113(104375)2020.PubMed/NCBI View Article : Google Scholar
15	Wang Y, Mao Y, Zhang X, Liu H, Peng W, Liang L, Shi M, Xiao Y, Zhang Y, Zhang F, et al: TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein. Life Sci. 228:1–10. 2019.PubMed/NCBI View Article : Google Scholar
16	Kajino T, Omori E, Ishii S, Matsumoto K and Ninomiya-Tsuji J: TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation. J Biol Chem. 282:9475–9481. 2007.PubMed/NCBI View Article : Google Scholar
17	Satirapoj B and Adler SG: Prevalence and Management of Diabetic Nephropathy in Western Countries. Kidney Dis. 1:61–70. 2015.PubMed/NCBI View Article : Google Scholar
18	Zhang Q, Li Y and Chen L: Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms. Zhongguo Zhongyao Zazhi. 40:1660–1665. 2015.PubMed/NCBI(In Chinese).
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
20	Mise K, Ueno T, Hoshino J, Hazue R, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, et al: Nodular lesions in diabetic nephropathy: Collagen staining and renal prognosis. Diabetes Res Clin Pract. 127:187–197. 2017.PubMed/NCBI View Article : Google Scholar
21	Kato M, Park JT and Natarajan R: MicroRNAs and the glomerulus. Exp Cell Res. 318:993–1000. 2012.PubMed/NCBI View Article : Google Scholar
22	Loboda A, Sobczak M, Jozkowicz A and Dulak J: TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation. Mediators Inflamm. 2016(8319283)2016.PubMed/NCBI View Article : Google Scholar
23	Sun Z, Ma Y, Chen F, Wang S, Chen B and Shi J: miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Eur J Pharmacol. 837:96–104. 2018.PubMed/NCBI View Article : Google Scholar
24	Deheuninck J and Luo K: Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res. 19:47–57. 2009.PubMed/NCBI View Article : Google Scholar
25	Ma T-T and Meng XM: TGF-β/Smad and Renal Fibrosis. Adv Exp Med Biol. 1165:347–364. 2019.PubMed/NCBI View Article : Google Scholar
26	Stroschein SL, Wang W, Zhou S, Zhou Q and Luo K: Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science. 286:771–774. 1999.PubMed/NCBI View Article : Google Scholar
27	Ciechanover A, Orian A and Schwartz AL: The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications. J Cell Biochem Suppl. 34:40–51. 2000.PubMed/NCBI View Article : Google Scholar
28	Inoue Y and Imamura T: Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci. 99:2107–2112. 2008.PubMed/NCBI View Article : Google Scholar
29	Li XZ, Feng JT, Hu CP, Chen ZQ, Gu QH and Nie HP: Effects of Arkadia on airway remodeling through enhancing TGF-beta signaling in allergic rats. Lab Invest. 90:997–1003. 2010.PubMed/NCBI View Article : Google Scholar
30	Briones-Orta MA, Levy L, Madsen CD, Das D, Erker Y, Sahai E and Hill CS: Arkadia regulates tumor metastasis by modulation of the TGF-β pathway. Cancer Res. 73:1800–1810. 2013.PubMed/NCBI View Article : Google Scholar
31	Levy L, Howell M, Das D, Harkin S, Episkopou V and Hill CS: Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol. 27:6068–6083. 2007.PubMed/NCBI View Article : Google Scholar
32	Tan R, He W, Lin X, Kiss LP and Liu Y: Smad ubiquitination regulatory factor-2 in the fibrotic kidney: Regulation, target specificity, and functional implication. Am J Physiol Renal Physiol. 294:F1076–F1083. 2008.PubMed/NCBI View Article : Google Scholar